Online Courses (English)
This just in:

State PCS

Daily Updates

Science & Technology

Concerns Over Use of BCG Vaccine: WHO

  • 02 May 2020
  • 3 min read

Why in News

The World Health Organization (WHO) has highlighted a few critical issues over the use of BCG vaccine for Covid-19.

Key Points

  • WHO emphasizes the importance of randomised controlled trials of the vaccine to understand its safety and efficacy before using it on healthcare workers.
    • Randomised controlled trials using BCG vaccine are under way in the Netherlands and Australia to find out whether the vaccine can reduce the incidence and severity of Covid-19.
  • According to an earlier study, there is an association between countries that have a universal BCG vaccination and reduced coronavirus cases.
    • It argues that countries that have deployed the BCG vaccine in their immunisation programmes have seen fewer deaths from Covid-19.
    • The BCG vaccine enhances the innate immune response to subsequent infections which might reduce viral load after Covid-19 exposure, with a consequent less severe Covid-19 and more rapid recovery.
  • Views in India:
    • According to the Translational Health Science and Technology Institute (THSTI), Faridabad, the vaccine can prevent intracellular infections, so its protective effects against Covid-19 is a biologically plausible hypothesis.
    • It will be premature for India, that has had a consistent TB vaccination policy since 1968, to take comfort from the study.
  • Five reasons countries should wait for the results of the BCG vaccine randomised controlled trials:
    • The association of fewer Covid-19 cases in countries that have a universal BCG vaccination programme is based on population rather than individual data.
    • The benefits of the BCG vaccine given at birth are unlikely to reduce the severity of Covid-19 decades later.
      • The beneficial effects of the BCG vaccine might be altered by subsequent administration of a different vaccine and become less effective after longer periods.
    • There is a remote possibility that the BCG vaccine ramps up the immune system leading to worsening of Covid-19 in a small population of patients with a severe disease.
    • If BCG vaccination is not effective against the novel coronavirus, it is likely to give a false sense of security to people, especially during the pandemic.
    • Using the vaccine without evidence of its benefits could further jeopardise the already short supply of the BCG vaccine.

Source: TH

SMS Alerts
Share Page